Springhill Fund Asset Management’s Bright Minds Biosciences DRUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-60,648
Closed -$2.18M – 25
2024
Q4
$2.18M Buy
+60,648
New +$2.13M 3.55% 13

Other funds holding DRUG

Springhill Fund Asset Management's DRUG Position: Q1 2025 in Review

Springhill Fund Asset Management sold out of Bright Minds Biosciences (DRUG) in Q1 2025, closing a stake of 60,648 shares — an estimated $2.18M sold.

Springhill Fund Asset Management first reported a position in DRUG in Q4 2024 and held it in 1 quarter. The position peaked at $2.18M in Q4 2024. 34 funds tracked by Wall St. Rank hold DRUG as of Q1 2025.

  • Springhill Fund Asset Management reported no remaining Bright Minds Biosciences position as of Q1 2025 after selling out during the quarter.
  • Springhill Fund Asset Management sold 60,648 Bright Minds Biosciences shares in Q1 2025, an estimated $2.18M.
  • Springhill Fund Asset Management first reported a position in Bright Minds Biosciences in Q4 2024 and held it in 1 quarter.
  • Springhill Fund Asset Management's Bright Minds Biosciences position peaked at $2.18M in Q4 2024.
  • 34 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2025.

Based on Springhill Fund Asset Management's 13F filing for Q1 2025, filed 14 May 2025.